Appointment of Chief Financial Officer
Quantum Pharma Plc (AIM: QP.), the service-led niche pharmaceutical developer, manufacturer and supplier to the health and care sectors, is pleased to announce the appointment of Gerard (Ged) Murray to the Board as Chief Financial Officer (CFO) with effect from 23 January 2017. Chris Rigg, Quantum's CEO, will continue in his joint role as CEO and CFO until that date.
Gerard brings with him a wealth of experience, having been finance director for a number of publicly quoted companies. He qualified as a Chartered Accountant with Arthur Andersen and spent over ten years serving as CFO and then CEO of Reg Vardy plc before joining Northgate plc as group finance director for a five year period. Both of these quoted companies experienced considerable growth during the periods that he served on their respective boards. Gerard also has sector experience from a period as group finance director of Immunodiagnostic Systems Holdings PLC. More recently he led the sale of Benfield Motor Group, a family owned motor retailer for £87.5 million to Lookers plc in September 2015 before joining Ardent Hire Solutions Limited, a private equity backed plant hire business, where he has been the CFO since April 2016.
Commenting on the appointment, Chris Rigg, CEO and CFO of Quantum Pharma Plc, said: "I am delighted that Ged is joining Quantum as our new CFO. He has an excellent track record and reputation, having worked as finance director for a number of well-known and respected public companies and will further strengthen and complement the Board. The Board joins me in welcoming him to Quantum and we look forward to benefiting from his considerable knowledge and experience in helping drive our focused and simplified business forward and generating value for our shareholders."
Posted by: Quantum Webmaster on 8th December 2016